TY - JOUR
AU - Vitola, Barbara
AB - INVITED EDITORIAL European Journal of Preventive Cardiology (2024) 31, 1861–1862 https://doi.org/10.1093/eurjpc/zwae319 Lipid-lowering therapy after myocardial infarction: strike early, strong, and equally in women and men 1,2 3,4 Gal Tsaban and Barbara Vitola * 1 2 3 Department of Cardiovascular Medicine, Mayo Clinic, Rochester, MN, USA; Faculty of Health Sciences, Ben Gurion University of the Negev, Be’er Sheva, Israel; Latvian Centre of Cardiology, Pauls Stradins Clinical University Hospital, LV-1002 Riga, Latvia; and Faculty of Medicine, Riga Stradins University, LV-1007 Riga, Latvia Online publish-ahead-of-print 28 September 2024 This editorial refers to ‘Prognostic impact of high-intensity meta-analyses indicate that the benefits of LLTs do not differ significantly lipid-lowering therapy under-prescription after acute myo- by sex. Consequently, clinical guidelines advocate lowering LDL-c to be- cardial infarction in women’, by O. Weizman et al., https:// low 55 mg/dL and reducing baseline levels by over 50% for both sexes. doi.org/10.1093/eurjpc/zwae255. Despite advancements in cardiovascular medicine and ongoing efforts to standardize care, women are still less likely to receive guideline- Intensive lipid-lowering therapies (LLTs) are pivotal in long-term cardio- directed treatment after MI and tend to have poorer outcomes vascular prevention, particularly in secondary prevention settings. The as- compared with men. Hand in hand, there are 
TI - Lipid-lowering therapy after myocardial infarction: strike early, strong, and equally in women and men
JO - European Journal of Preventive Cardiology
DO - 10.1093/eurjpc/zwae319
DA - 2024-09-28
UR - https://www.deepdyve.com/lp/oxford-university-press/lipid-lowering-therapy-after-myocardial-infarction-strike-early-strong-5lAKc7KRIR
SP - 1861
EP - 1862
VL - 31
IS - 15
DP - DeepDyve
ER -